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Aim To compare the quality of the 2008 cancer mortality 
data of the Istanbul Directorate of Cemeteries (IDC) with 
the 2008 data of International Agency for Research on Can-
cer (IARC) and Turkish Statistical Institute (TUIK), and dis-
cuss the suitability of using this databank for estimations 
of cancer mortality in the future.
Methods We used 2008 and 2010 death records of the IDC 
and compared it to TUIK and IARC data.
Results According to the WHO statistics, in Turkey in 2008 
there were 67 255 estimated cancer deaths. As the popula-
tion of Turkey was 71 517 100, the cancer mortality rate was 
9.4 per 10 000. According to the IDC statistics, the cancer 
mortality rate in Istanbul in 2008 was 5.97 per 10 000.
Conclusion IDC estimates were higher than WHO prob-
ably because WHO bases its estimates on a sample group 
and because of the restrictions of IDC data collection 
method. Death certificates could be a reliable and accu-
rate data source for mortality statistics if the problems of 
data collection are solved.
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Due to the rapid aging of populations, diet, use of tobacco 
and other substances (cannabis etc), and infectious agents, 
cancer remains a major cause of morbidity and mortality 
worldwide. Incidence rates of many cancers could increase 
substantially in the future, with up to 15 million new cases 
expected in 2020. Most of them will occur in developing 
countries (1,2). Although the overall incidence of cancer in 
developing countries is still lower than in the developed 
world, the mortality rate of cancer is comparable (3). In 
order to adequately respond to the growing cancer pan-
demic in developing countries, we should gather informa-
tion, use that information to determine priorities, and im-
plement appropriate initiatives (4).
Developing countries largely lack effective cancer surveil-
lance and control, adequate health care, funding, and cov-
erage at the national level. The magnitude of the cancer 
burden is poorly understood owing to a lack of surveil-
lance and monitoring systems for cancer risk factors and a 
lack of documentation of cancer incidence and mortality. 
Surveillance of cancer, as well as a well-functioning data 
collection mechanism, is critical to the implementation 
and evaluation of primary and secondary prevention (2) 
and to understanding of the cancer burden (5). The “gold-
standard” in cancer surveillance is a population-based can-
cer registry. Through this registry, information on new can-
cer cases could be systematically and continually collected. 
The data from such a registry would allow for the calcula-
tion of cancer incidence rates when used with correspond-
ing census data. Such cancer registries require sustained 
commitments and trained personnel, which are also lack-
ing in many countries (5).
Crucial steps in cancer surveillance are improving infra-
structure and training capacity for gathering of cancer in-
cidence, prevalence, and mortality data. Accurate statistics 
on cancer occurrence and outcome are essential both for 
the research purposes and for the planning and evalua-
tion of programs for cancer control (6). However, statistics 
on cancer incidence and mortality available in developing 
countries are often incomplete. This creates a challenge 
to policy and resource allocation, as epidemiologic data 
are crucial for identification of cancer risk factors and eti-
ologies (7).
Several international agencies have published statistics on 
cancer mortality rates and incidence, including those from 
developing countries. The International Agency for Re-
search on Cancer (IARC), a component of the WHO (6), pe-
riodically collects data and produces estimates of cancer 
incidence and mortality for all countries, whether a cancer 
registry exists or not. These estimates are updated periodi-
cally on GLOBOCAN projects (5).
GLOBOCAN is a project conducted by IARC, which pres-
ents the estimates of cancer incidence and mortality from 
major types of cancers of 184 countries or territories of the 
world (8). Cancer Incidence in Five Continents (CI5), an 
IARC publication, provides information on the incidence 
of cancer recorded by cancer registries worldwide. CI5 is 
the product of the collaboration between the IARC and 
the network of cancer registries worldwide, represented 
by the International Association of Cancer Registries. Data 
from Turkey are provided by the Cancer Control Depart-
ment of the Ministry of Health (9). and refer to the provinc-
es of Izmir and Antalya. The population-based registry in 
Turkey was started in Izmir in 1991 and is run by the Cancer 
Control Department of the Ministry of Health. It has been 
extended to other provinces that are thought to be repre-
sentative of Turkey as a whole (8).
Incidence data are obtained from population-based can-
cer registries, and mortality data from vital registration sys-
tems, where the fact and “underlying” cause of death are 
certified by a medical practitioner (8). In Turkey, death cer-
tificates are issued by municipality physicians and family 
physicians. Hospital doctors issue the death certificate if 
the person dies in the hospital. Death certificates repre-
sent also the permission for burial. Copies of death certifi-
cates are sent both to the Provincial Directorates of Cem-
eteries under Municipalities and to the Community Health 
Centers of the Provincial Directorate of Health, which then 
forward the copy to the Turkish Statistical Institute (TUIK). 
TUIK is the institution that collects and publishes official 
economic, social, and demographic data (10). It also col-
lects death statistics. While incidence data are general-
ly published with some delay as they require time to be 
compiled, mortality data are easier to generate, especially 
if they are kept in a computerized system.
In this study, we compared the quality of the 2008 can-
cer mortality data of the Istanbul Directorate of Cemeter-
ies with the 2008 data of IARC and TUIK, and discussed the 
suitability of using this databank for estimations of cancer 
mortality in the future.
MaTErial and METhodS
We used 2008 and 2010 death records of the Istanbul 
Directorate of Cemeteries. A request was made to 
PUBLIC HEALTH482 Croat Med J. 2012;53:480-5
www.cmj.hr
the Directorate and in April of 2011 the data were provid-
ed. In the Directorate, data from death certificates hand-
written by physicians are transferred to computers. The 
personnel responsible for entering the data are non-medi-
cal staff. The variables that are taken into consideration are 
name, sex, age, address, time of death, cause of death, and 
burial place. In Turkey, it is not legal to perform burial with-
out a death certificate or anywhere other than in ceme-
teries. We may therefore assume that the Directorate data 
are comprehensive. As the same data are also kept in the 
Municipality, we requested that it should be cross checked 
and any irregularities accounted for. The TUIK mortality 
data can be accessed on line (10).
We accessed the 2008 IARC GLOBOCAN data in May 2011. 
The number of cancer deaths in Turkey in 2008 was esti-
mated from the incidence estimates calculated from the 
data provided by the cancer registry offices from two 2 
cities, which operate compatible with the standards of 
IARC, and site-specific survival using the gross domes-
tic product (GDP) after having made some corrections. 
GDP method estimates the relationship between cancer-
specific 5-year relative survival and country-specific GDP 
per capita based on the assumption that cancer survival 
is reasonably correlated with the level of GDP (11). The 
overall number of deaths was corrected for under-report-
ing or incompleteness using percentages provided by 
the WHO. When the category ill-defined cause of death 
exceeded 3% of the total causes of death, the excess was 
partitioned by sex and age into cancer deaths and other 
specific causes of death. The corrected cancer deaths cat-
egory was partitioned into cancer-specific categories us-
ing proportions from the non-corrected data. The num-
ber of cancer cases and cancer deaths was scaled to the 
estimated WHO total number of cancer deaths for 2008. 
WHO extracted national population estimates for 2008 
from the United Nations (UN) population division, the 
2008 revision (United Nations, Population Division, World 
Population Prospects, the 2008 revision, http://www.
un.org/).
rESUlTS
According to the WHO statistics, the estimated number of 
cancer deaths in 2008 was 67 255. As in the same year the 
population of Turkey was 71 517 100, the cancer mortality 
rate was 9.4 per 10 000. The four most mortal cancers were 
trachea, bronchus, and lung; stomach; colon and rectum; 
and breast cancer. These accounted for 47.7% of total 
cases (Table 1).
According to the statistics produced by the Istanbul Direc-
torate of Cemeteries, the number of cancer deaths in Istan-
bul in 2008 was 7500 (Table 2). As the population of Istan-
bul in the same year was 12 697 164, the cancer mortality 
TablE 2. The distribution of cancer deaths in istanbul by cause, 
2008*
deaths Mortality rate
Malignant neoplasms n % (100 000)
Trachea, bronchus, lung 2918  38.90 23.21
Stomach  737   9.82  5.86
Colon and rectum  706   9.41  5.61
Breast  435   5.80  3.46
Pancreas  391   5.21  3.11
Liver  284   3.78  2.25
Prostate  279   3.72  2.21
Lymphomas, multiple myeloma  179   2.38  1.42
Bladder  161   2.14  1.28
Ovary  149   1.98  1.18
Leukemia  115   1.53  0.91
Melanoma and other skin  103   1.37  0.81
Corpus uteri   88   1.17  0.70
Esophagus   66   0.88  0.52
Cervix uteri   18   0.24  0.14
Mouth and oropharynx   17   0.22  0.13
Other  854  11.45  6.79
Total 7500 100.00 59.67
*obtained from the istanbul directorate of Cemeteries.
TablE 1. World health organization estimates of cancer 
deaths in Turkey by cause, 2008
deaths Mortality rate
Malignant neoplasms n % (100 000)
Trachea, bronchus, lung 15 101 22.45 21.11
Stomach 7769 11.55 10.86
Colon and rectum 4949 7.30 6.92
Breast cancer 4311 6.40 6.02
Lymphomas, multiple myeloma 3516 5.22 4.91
Leukemia 2931 4.35 4.09
Bladder 2892 4.30 4.04
Esophagus 2878 4.27 4.02
Prostate 2853 4.24 3.98
Pancreas 1972 2.93 2.75
Liver 1536 2.28 2.14
Ovary 1247 1.85 1.74
Mouth and oropharynx 1232 1.83 1.72
Cervix uteri 556 0.84 0.77
Corpus uteri 519 0.77 0.72
Melanoma and other skin 401 0.60 0.56
Other 12592 18.79 17.6
Total 67 255 100.00 94.04
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rate was 5.97 per 10 000, by simply dividing the number of 
deaths with the population of Istanbul. If the cancer mor-
tality rate for Turkey estimated by WHO was weighed by 
2008 population of Istanbul relative to Turkey, the number 
of cancer deaths in Istanbul would be 11 814. In the same 
year, the number of death cases recorded by TUIK was 8640, 
which does not comprise the dead people transported to 
the city from the family’s place of origin. By using the same 
WHO classification, the four most prevalent types of cancer 
accounted for 62.93% of the total of cancer deaths.
The number of cancer deaths recorded by the Istanbul Di-
rectorate of Cemeteries in Istanbul in 2010 was 6896, while 
WHO and TUIK have not yet published any data for Turkey 
beyond 2008.
diSCUSSion
The number of cancer deaths in Istanbul was 7500 accord-
ing to the Istanbul Directorate of Cemeteries, 11 814 ac-
cording to the WHO (11), and 8640 according to TUIK. One 
of the reasons for the discrepancy is the influence of the 
variability of cancer risk in different populations. However, 
notwithstanding the differences, the prevalence of types 
of cancers seems to be entirely accurate. The first four can-
cers on the WHO list were exactly the same as those listed 
by the Directorate of Cemeteries. Similarly, in most of the 
developing countries, most frequent types of cancer were 
lung, breast, stomach, colorectal, and liver cancers (12-14).
WHO collects and presents mortality statistics worldwide. 
The data sets from different nations are not of the same 
quality. In some countries, coverage of the population is in-
complete, so mortality rates are low or the quality of cause 
of death information is poor. While almost all the European 
and American countries have comprehensive death regis-
tration systems, most of the developing countries do not. 
Official Turkish statistics are presented by TUIK, but IARC 
receives the cancer data from the Cancer Control Depart-
ment of the Ministry of Health, which is the specialized 
center for registration in Turkey.
TUIK obtains mortality data through Provincial Health Di-
rectorates from the death certificates filled out by munici-
pality doctors and family physicians, and in some cases, 
by hospital doctors. The key task in filling out the certif-
icates is to record the cause of death correctly, for the 
purpose of which there are 4 lines, marked a-d. The top 
line should state the “end cause,” with the following lines 
going down to the “main cause.” Diseases such as cancer 
should be recorded on the “d” line, with the immediate 
cause, for example sepsis or anaphylaxis, on the “a” line. As 
a result, even when doctors are clear about the cause of 
death, they may not record it correctly in terms of order. 
Data on death events occurring in province and district 
centers are classified by TUIK in compliance with interna-
tional standards and in accordance with the International 
Disease Categories (ICD-8), which list 50 and 150 causes 
for tabulation of mortality as required by the WHO. Mor-
tality statistics are evaluated and presented annually to 
the public.
The other institution that collects death certificates and 
keeps these records is the Directorates of the Cemeter-
ies under Municipalities. Although in both cases, death 
certificates are the only source used to extract the data, 
there is a difference between the TUIK statistics and those 
of the Directorates of Cemeteries. TUIK specializes in pro-
cessing statistics, so its personnel are more likely to ex-
tract the key information even when it is not in the cor-
rect order. While staff working on the databanks of the 
cemeteries may simply transfer information from the “d” 
line of the certificate, the personnel in TUIK are trained to 
seek the “main cause” among the given causes. Because 
of this, the calculation of cancer registry from death cer-
tificates is widely accepted as non-reliable. IARC claims 
in its World Cancer Report 2003 that any rate calculated 
from death certificates would be below the actual figure, 
which is the case in our study.
The WHO data cover entire national populations but more 
often they cover smaller, subnational areas or only major 
cities, particularly in developing countries. National mor-
tality rates in some countries have a correction factor ap-
plied to account for known and quantified underreporting 
of deaths. Rates for the missing sites are computed using 
proportions from mortality files provided by the reliable 
part of cancer registries. When national mortality data are 
unavailable or are of poor quality, regional mortality rates 
derived from the data of one or more cancer registries cov-
ering a part of the country are used and mortality is esti-
mated from incidence rates, using country/region-specific 
survival (8). The WHO data may also contain an error, which 
is assumed to be tolerable. The cancer morbidity figures 
from Sample Registry System were low compared with the 
cancer registry of Health Ministry figures (15).
Registries collect the data on cancer deaths from three 
main sources: municipal health directorates through 
physicians who report the death; hospital medical 
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records; and active follow-up through telephone, postal 
enquiries, and house visits. There are many reasons for un-
der-registration of cancer deaths in cancer registries: the 
death might have occurred outside the area of registration, 
it may not have been registered at the municipal health 
directorate, or the cancer may have been overlooked; if 
the cancer has long survival the information about cancer 
could have been totally forgotten. Also, migration plays an 
important role, and cause of death may be erroneously re-
ported as the last cause of death instead of the main rea-
son (16).
Nonetheless, death certificates that are normally ignored 
when death rates are calculated have the potential to 
provide an important supplementary source of informa-
tion for cancer registries. As far as incidence statistics are 
concerned, they function as a means of capturing infor-
mation on cases that were omitted in the registration pro-
cess. Cancer registries may evaluate the completeness of 
their work on the basis of the proportion of incident can-
cers that first come to the registry’s attention via a Death 
Certificate Notification of cancer (DCN) (17). In that case 
the DCN cases are measured against the Death Certificate 
Only (DCO) cases, for which no other information than a 
death certificate mentioning cancer could be obtained. 
The DCO cases fail to show any evidence (disease report, 
official document, etc.) other than death certificate. An el-
evated DCO percentage is suggestive of incompleteness. 
But, of course, this must be interpreted in the light of lo-
cal circumstances, since the quality of the already existing 
death certificates may be very poor, as is the case in some 
developing countries. In the Volume IX of CI5 of IARC, data 
sets with less than 20% of DCO cases were considered for 
the evaluation (18).
On the other hand, another measure of validity could be the 
proportion of cancers for which no other information other 
than a death certificate mentioning cancer can be obtained 
(18). The information on death certificates is known to suf-
fer from lack of accuracy, or lack of precision, compared with 
that obtained from clinical or pathology records (19).
The IARC data may contain some errors because they are 
based upon a sampling system. It is a generalized esti-
mation based on a sample group, so countries should 
establish more reliable data collection systems. For mor-
tality statistics, death certificates can be a more reli-
able and accurate data source, if sufficient attention is 
paid to them. The quality of mortality data could be 
enhanced by establishing computerized systems, 
checking the data input, and training the physicians and 
system analysts.
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